SG11201400331WA - Novel betulinic acid derivatives with antiviral activity - Google Patents
Novel betulinic acid derivatives with antiviral activityInfo
- Publication number
- SG11201400331WA SG11201400331WA SG11201400331WA SG11201400331WA SG11201400331WA SG 11201400331W A SG11201400331W A SG 11201400331WA SG 11201400331W A SG11201400331W A SG 11201400331WA SG 11201400331W A SG11201400331W A SG 11201400331WA SG 11201400331W A SG11201400331W A SG 11201400331WA
- Authority
- SG
- Singapore
- Prior art keywords
- acid derivatives
- antiviral activity
- betulinic acid
- novel betulinic
- novel
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical class C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161537099P | 2011-09-21 | 2011-09-21 | |
| PCT/US2012/056186 WO2013043778A1 (en) | 2011-09-21 | 2012-09-20 | Novel betulinic acid derivatives with antiviral activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201400331WA true SG11201400331WA (en) | 2014-08-28 |
Family
ID=46964090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201400331WA SG11201400331WA (en) | 2011-09-21 | 2012-09-20 | Novel betulinic acid derivatives with antiviral activity |
Country Status (15)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8906889B2 (en) * | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
| US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
| AU2016248068B2 (en) * | 2015-04-14 | 2018-07-26 | ViiV Healthcare UK (No.4) Limited | Methods of producing an HIV maturation inhibitor |
| JP2018521107A (ja) | 2015-07-28 | 2018-08-02 | グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ | Ｈｉｖ感染を予防または治療するためのベツイン誘導体 |
| CA2993753A1 (en) | 2015-07-28 | 2017-02-02 | Glaxosmithkline Intellectual Property (No.2) Limited | Betuin derivatives for preventing or treating hiv infections |
| JP2018528231A (ja) | 2015-09-24 | 2018-09-27 | グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ | Ｈｉｖ成熟阻害活性を有する化合物 |
| BR112018014622A2 (pt) | 2016-01-20 | 2018-12-11 | Glaxosmithkline Ip No 2 Ltd | ?composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos para tratar uma infecção por hiv e para prevenir uma infecção por hiv, e, uso de um composto ou sal? |
| US20190307776A1 (en) * | 2016-06-30 | 2019-10-10 | Viiv Healthcare Uk (No. 5) Limited | Aza-substituted inhibitors of human immunodeficiency virus replication |
| EP3784349B1 (en) | 2018-04-24 | 2023-12-27 | VIIV Healthcare UK (No.5) Limited | Compounds with hiv maturation inhibitory activity |
| EP3796900A4 (en) | 2018-06-29 | 2022-03-30 | DFH Therapeutics | TRITERPENE AMINE DERIVATIVES |
| EA202192111A1 (ru) * | 2019-02-11 | 2022-01-26 | Хетеро Лабс Лимитед | Новые тритерпеновые производные в качестве ингибиторов вич |
| WO2021161206A1 (en) * | 2020-02-11 | 2021-08-19 | Hetero Labs Limited | Novel triterpene derivatives as hiv inhibitors |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| US5869535A (en) | 1995-03-21 | 1999-02-09 | The Board Of Trustees Of The University Of Illinois | Method and composition for selectively inhibiting melanoma |
| US5962527A (en) | 1995-03-21 | 1999-10-05 | The Board Of Trustees Of The University Of Illinois | Method and composition for treating cancers |
| US5679828A (en) | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
| US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US7365221B2 (en) | 2002-09-26 | 2008-04-29 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| US20050014730A1 (en) | 2003-04-02 | 2005-01-20 | Carlson Robert M. | Anti-fungal formulation of triterpene and essential oil |
| US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| US20050239748A1 (en) | 2004-03-17 | 2005-10-27 | Panacos Pharmaceuticals, Inc. | Pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl) betulinic acid |
| TW200628161A (en) | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| WO2008127364A2 (en) | 2006-10-13 | 2008-10-23 | Myriad Genetics, Inc. | Antiviral compounds and use thereof |
| US20110144069A1 (en) | 2006-10-16 | 2011-06-16 | Myriad Genetics, Incorporated | Compounds for treating viral infections |
| AU2009214779A1 (en) * | 2008-02-14 | 2009-08-20 | Virochem Pharma Inc. | Novel 17beta lupane derivatives |
| US9067966B2 (en) * | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
| ES2548905T3 (es) | 2010-06-04 | 2015-10-21 | Bristol-Myers Squibb Company | Amidas C-28 de derivados del ácido betulínico C-3 modificados como inhibidores de la maduración del VIH |
| EA022393B1 (ru) | 2010-06-04 | 2015-12-30 | Бристол-Майерс Сквибб Компани | С-3 модифицированные производные бетулиновой кислоты в качестве ингибиторов созревания вич |
| MX2013008359A (es) | 2011-01-31 | 2013-08-27 | Bristol Myers Squibb Co | Aminas de c-28 de derivados de acido betulinico modificado de c-3 como inhibidores de la maduracion del virus de inmunodeficiencia humana. |
| EA022470B1 (ru) | 2011-01-31 | 2016-01-29 | Бристол-Маерс Сквибб Компани | C-17 и c-3 модифицированные тритерпеноиды с ингибиторной активностью созревания вич |
-
2012
- 2012-09-20 AU AU2012312485A patent/AU2012312485B2/en not_active Ceased
- 2012-09-20 EP EP12766825.9A patent/EP2758419B8/en not_active Not-in-force
- 2012-09-20 US US13/623,165 patent/US8754069B2/en not_active Expired - Fee Related
- 2012-09-20 JP JP2014531936A patent/JP6100786B2/ja not_active Expired - Fee Related
- 2012-09-20 CA CA2849475A patent/CA2849475A1/en not_active Abandoned
- 2012-09-20 WO PCT/US2012/056186 patent/WO2013043778A1/en active Application Filing
- 2012-09-20 EA EA201490643A patent/EA023463B1/ru not_active IP Right Cessation
- 2012-09-20 TW TW101134558A patent/TW201317255A/zh unknown
- 2012-09-20 KR KR1020147010087A patent/KR20140069167A/ko not_active Ceased
- 2012-09-20 SG SG11201400331WA patent/SG11201400331WA/en unknown
- 2012-09-20 ES ES12766825.9T patent/ES2611727T3/es active Active
- 2012-09-20 BR BR112014006559A patent/BR112014006559A2/pt not_active IP Right Cessation
- 2012-09-20 MX MX2014002936A patent/MX2014002936A/es unknown
- 2012-09-20 CN CN201280046037.7A patent/CN103814042B/zh not_active Expired - Fee Related
-
2014
- 2014-03-09 IL IL231421A patent/IL231421A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013043778A1 (en) | 2013-03-28 |
| CN103814042A (zh) | 2014-05-21 |
| AU2012312485A1 (en) | 2014-05-08 |
| JP2014526554A (ja) | 2014-10-06 |
| EA023463B1 (ru) | 2016-06-30 |
| JP6100786B2 (ja) | 2017-03-22 |
| IL231421A0 (en) | 2014-04-30 |
| EA201490643A1 (ru) | 2014-06-30 |
| BR112014006559A2 (pt) | 2017-03-28 |
| ES2611727T3 (es) | 2017-05-10 |
| US20130072465A1 (en) | 2013-03-21 |
| EP2758419A1 (en) | 2014-07-30 |
| TW201317255A (zh) | 2013-05-01 |
| IL231421A (en) | 2015-11-30 |
| US8754069B2 (en) | 2014-06-17 |
| MX2014002936A (es) | 2014-04-25 |
| EP2758419B8 (en) | 2017-04-19 |
| CN103814042B (zh) | 2015-08-19 |
| CA2849475A1 (en) | 2013-03-28 |
| KR20140069167A (ko) | 2014-06-09 |
| AU2012312485B2 (en) | 2016-09-01 |
| EP2758419B1 (en) | 2016-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL231421A0 (en) | Innovative derivatives of betulinic acid with antiviral activity | |
| IL252345A0 (en) | Antiviral compounds | |
| AP2013006707A0 (en) | 2-Quinolinyl-acetic acid derivatives as HIV antiviral compounds | |
| EP2715539A4 (en) | DISTRIBUTED CALCULATION FRAMEWORK | |
| IL250370A0 (en) | Propionic acid derivatives substituted with heteroaroylamino in position 3 and their use as pharmaceuticals | |
| IL249826A0 (en) | Propionic acid derivatives converted in 3-heteroylamino and their use in pharmaceutical preparations | |
| EP2799494A4 (en) | SOLUTION OF POLYAMIC ACID | |
| GB201111742D0 (en) | Solution | |
| EP2719552A4 (en) | MOUNTING STRUCTURE | |
| EP2664621A4 (en) | virucidal | |
| EP2699241A4 (en) | ANTIVIRAL COMPOUNDS | |
| ZA201400918B (en) | Pyrrolidine-3-ylacetic acid derivative | |
| EP2691106A4 (en) | ANTIVIRAL COMPOSITION | |
| EP2782902A4 (en) | DERIVATIVES FROM PHENOXYISOBUTTERIC ACID | |
| ZA201306909B (en) | Antiviral composition | |
| GB201121309D0 (en) | Antiviral | |
| GB201121966D0 (en) | Antiviral drug derivatives | |
| GB201121968D0 (en) | Antiviral drug derivatives | |
| ZA201402374B (en) | Antiviral compounds | |
| PL394696A1 (pl) | Pochodna leku przeciwwirusowego | |
| PL2734068T3 (pl) | Układ zapięcia | |
| GB201101757D0 (en) | Measuring aerobic activity | |
| PL2599998T3 (pl) | Skrzydło fotowoltaiczne | |
| GB201105578D0 (en) | Osteoclast activity |